Stock-Based Compensation

$427.04K

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$427.04Kperiod endingJun 30, 2026

APRE TTM Stock-Based Comp ($531.13K → $427.04K)

TTM stock-based compensation

High-resolution chart · PNG

APRE stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aprea Therapeutics, Inc. Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period ending	Stock-Based Compensation (USD)
Jun 30, 2026	427,039
Mar 31, 2026	460,575
Dec 31, 2025	478,141
Sep 30, 2025	495,145
Jun 30, 2025	530,481
Mar 31, 2025	522,240
Dec 31, 2024	489,436
Sep 30, 2024	446,269
Jun 30, 2024	373,210
Mar 31, 2024	514,045
Dec 31, 2023	444,459
Sep 30, 2023	418,953
Jun 30, 2023	381,158
Mar 31, 2023	14,913,450
Dec 31, 2022	16,981,266
Sep 30, 2022	19,015,003
Jun 30, 2022	21,013,358
Mar 31, 2022	8,075,241
Dec 31, 2021	7,813,743
Sep 30, 2021	7,154,096
Jun 30, 2021	5,117,505
Mar 31, 2021	4,510,467
Dec 31, 2020	3,593,376
Sep 30, 2020	2,161,931
Jun 30, 2020	2,408,156
Mar 31, 2020	1,338,659
Dec 31, 2019	531,134
Sep 30, 2019	610,673
Jun 30, 2019	444,239